Published in J Neurochem on January 01, 1990
CK-MM PGAM-MM G6PD and am biochemical markers of functional innervated cultured human muscle fibers. Cytotechnology (1991) 0.75
The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female. Neurology (1969) 2.94
Inclusion body myositis and myopathies. Ann Neurol (1995) 2.68
Selective and nonselective susceptibility of muscle fiber types. A new approach to human neuromuscular diseases. Arch Neurol (1970) 2.33
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology (1977) 2.19
Benefit from alternate-day prednisone in myasthenia gravis. N Engl J Med (1972) 2.00
Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci U S A (2001) 1.94
The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology (1969) 1.93
Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med (1972) 1.90
Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Lancet (1983) 1.90
Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet (1975) 1.84
Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol (1996) 1.82
Ocular motor abnormalities in hereditary cerebellar ataxia. Brain (1976) 1.79
Single cholinergic receptor channel currents in cultured human muscle. J Neurosci (1982) 1.79
Oculocraniosomatic neuromuscular disease with "ragged-red" fibers. Arch Neurol (1972) 1.72
Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med (1974) 1.69
The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of the upper and lower motor neuron. Neurology (1969) 1.64
Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol (1996) 1.51
beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol (1993) 1.49
Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol (1981) 1.48
Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection. Lancet (1978) 1.48
Histochemical studies of denervated or tenotomized cat muscle: illustrating difficulties in relating experimental animal conditions to human neuromuscular diseases. Ann N Y Acad Sci (1966) 1.48
Type I fiber hypotrophy and central nuclei. A rare congenital muscle abnormality with a possible experimental model. Arch Neurol (1968) 1.47
Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol (1992) 1.47
"Type grouping" in skeletal muscles after experimental reinnervation. Neurology (1968) 1.46
Tubular aggregates in type II muscle fibers: ultrastructural and histochemical correlation. J Ultrastruct Res (1970) 1.42
Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness. Ann Intern Med (1970) 1.41
Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol (1994) 1.37
Axonal transport of proteins in experimental neuropathies. Science (1969) 1.36
Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci U S A (1996) 1.33
A new program for investigating adult human skeletal muscle grown aneurally in tissue culture. Neurology (1975) 1.31
Polymyositis: remarkable response to total body irradiation. Lancet (1981) 1.30
The histographic analysis of human muscle biopsies with regard to fiber types. 3. Myotonias, myasthenia gravis, and hypokalemic periodic paralysis. Neurology (1969) 1.29
The essentiality of histo- and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease. 1962. Neurology (1998) 1.27
Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy. Arch Neurol (1970) 1.26
Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions. Science (1971) 1.26
Histochemical investigation of fiber type ratios with the myofibrillar ATP-ase reaction in normal and denervated skeletal muscles of guinea pig. Am J Anat (1968) 1.22
Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.22
Impaired skeletal muscle maturation following neonatal neurectomy. Dev Biol (1968) 1.21
Neuronal trophic function. A new aspect demonstrated histochemically in developing soleus muscle. Arch Neurol (1967) 1.20
Correlative histochemical study of skeletal muscle after suprasegmental denervation, peripheral nerve section, and skeletal fixation. Neurology (1968) 1.20
Subacute sclerosing panencephalitis. Spontaneous improvement in a patient with elevated measles antibody in blood and spinal fluid. N Engl J Med (1968) 1.19
beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport (1993) 1.19
Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology (2010) 1.19
Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management. Arch Neurol (1984) 1.18
Increased plasma enzyme concentrations in rats with functional ischaemia of muscle provide a possible model of Duchenne muscular dystrophy. Nature (1972) 1.17
A histochemical-physiological correlation of frog skeletal muscle fibers. Am J Physiol (1967) 1.17
Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med (1968) 1.16
Neuromuscular disease in secondary hyperparathyroidism. Ann Intern Med (1975) 1.15
Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci Lett (1991) 1.15
Polyneuropathy with monoclonal gammopathy: studies of 11 patients. Ann Neurol (1981) 1.14
Refsum's disease--a recently characterized lipidosis involving the nervous system. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1967) 1.13
Slow saccades in spinocerebellar degeneration. Arch Neurol (1976) 1.13
Ultrastructural localization of calcium in normal and abnormal skeletal muscle. Lab Invest (1977) 1.13
Open-biopsy electromyography. I. Correlation of motor unit behavior with histochemical muscle fiber type in human limb muscle. Arch Neurol (1972) 1.13
Cardiac manifestations in polymyositis. Am J Cardiol (1978) 1.13
High injection pressure during intralesional injection of corticosteroids into capillary hemangiomas. Arch Ophthalmol (2001) 1.11
The multiple ADP/ATP translocase genes are differentially expressed during human muscle development. J Biol Chem (1992) 1.11
Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology (1993) 1.11
Histochemical and contractile properties in the cross-innervated guinea pig soleus muscle. Arch Neurol (1969) 1.10
Scanning for soft-tissue amyloid. Lancet (1977) 1.10
Muscle biopsies in neuromuscular diseases. Pediatr Clin North Am (1967) 1.10
Neuropathy in Tangier disease. Alpha-Lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage. Arch Neurol (1967) 1.09
Ultrastructural study of a peripheral nerve biopsy in Refsum's disease. J Neuropathol Exp Neurol (1969) 1.08
Atrophy of skeletal muscle in patients with Cushing's syndrome. Arch Neurol (1970) 1.08
The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis: an electron microscopic immunohistochemical study using peroxidase conjugated antibody fragments. J Immunol (1973) 1.07
The pathogenesis of reactive axonal swellings: role of axonal transport. J Neuropathol Exp Neurol (1977) 1.05
A skeletal-muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism. N Engl J Med (1970) 1.04
Families with myotonic dystrophy with and without cardiac involvement. Arch Intern Med (1983) 1.04
Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol (1998) 1.03
Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism. Lancet (1970) 1.03
Does myasthenic serum bind to the neuromuscular junction? Ann N Y Acad Sci (1966) 1.03
Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging. Scand J Rheumatol (1998) 1.03
Phytanic acid in patients with Refsum's syndrome and response to dietary treatment. Arch Intern Med (1970) 1.03
Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases. Lancet (1994) 1.02
Focal myopathic changes produced by electromyographic and hypodermic needles. "Needle myopathy". Arch Neurol (1967) 1.01
The histologic diagnosis of neuromuscular diseases: a review of 79 biopsies. Arch Phys Med Rehabil (1966) 1.01
Intravenous treatment of hypokalemic periodic paralysis. Arch Neurol (1983) 1.01
New advances in inclusion-body myositis. Curr Opin Rheumatol (1993) 1.00
Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy. Am J Pathol (1998) 1.00
Transformation of the histochemical profile of skeletal muscle by "foreign" innervation. Nature (1967) 1.00
Beta APP gene transfer into cultured human muscle induces inclusion-body myositis aspects. Neuroreport (1997) 1.00
Amyloidosis with plasma cell dyscrasia. An overlooked caused of adult onset sensorimotor neuropathy. Arch Neurol (1977) 0.99
In vitro analysis of the general properties and junctional receptor characteristics of skeletal muscle membranes. Isolation, purification, and partial characterization of sarcolemmal fragments. Proc Natl Acad Sci U S A (1974) 0.99
Systemic manifestations of gyrate atrophy of the choroid and retina. Ophthalmology (1981) 0.99
Myasthenia gravis: a new hypothesis of the pathogenesis and a new form of treatment. Ann N Y Acad Sci (1971) 0.98
Human schwann cells in tissue culture: histochemical and ultrastructural studies. Arch Neurol (1980) 0.98
Brief, small, abundant motor-unit action potentials. A further critique of electromyographic interpretation. Neurology (1975) 0.98
Collagen localization in normal and fibrotic human skeletal muscle. Arch Neurol (1981) 0.98
Improved technique for electron microscopy of cultured cells. Stain Technol (1977) 0.97
Treatment of "permanent" muscle weakness in familial Hypokalemic Periodic Paralysis. Muscle Nerve (1983) 0.97
Strong immunoreactivity of alpha 1-antichymotrypsin co-localizes with beta-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis. Acta Neuropathol (1993) 0.97